Imaxio's Unattributed Round

Imaxio raised a round of funding on April 17, 2012. Investors include Pradeyrol Recherche-Developpement.

Imaxio is an integrated biotech company focused on vaccines and genomics, and based on the combination of R&D and commercial activities: MX313: a technology platform using recombinant carrier protein…

Articles about Imaxio's Unattributed Round: